A propensity score weighted comparison of tebentafusp or pembrolizumab versus combination ipilimumab and nivolumab in untreated metastatic uveal melanoma Meeting Abstract
| Authors: | Piulats Rodriguez, J. M.; Piperno-Neumann, S.; Rutkowski, P.; Nathan, P.; Hassel, J. C.; Espinosa, E.; de la Cruz Merino, L.; Ochsenreither, S.; Shoushtari, A. N.; Orloff, M.; Salama, A. K. S.; Watkins, C.; Goodall, H.; Baurain, J. F. |
| Abstract Title: | A propensity score weighted comparison of tebentafusp or pembrolizumab versus combination ipilimumab and nivolumab in untreated metastatic uveal melanoma |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S924 |
| Language: | English |
| ACCESSION: | WOS:000866211601094 |
| DOI: | 10.1016/j.annonc.2022.07.949 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 823P -- Source: Wos |
